【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Pulmonary Fibrosis Overview 10
Therapeutics Development 11
Pipeline Products for Pulmonary Fibrosis – Overview 11
Pipeline Products for Pulmonary Fibrosis – Comparative Analysis 12
Pulmonary Fibrosis – Therapeutics under Development by Companies 13
Pulmonary Fibrosis – Therapeutics under Investigation by Universities/Institutes 19
Pulmonary Fibrosis – Pipeline Products Glance 20
Late Stage Products 20
Clinical Stage Products 21
Early Stage Products 22
Unknown Stage Products 23
Pulmonary Fibrosis – Products under Development by Companies 24
Pulmonary Fibrosis – Products under Investigation by Universities/Institutes 30
Pulmonary Fibrosis – Companies Involved in Therapeutics Development 31
AdAlta Pty Ltd. 31
Aeolus Pharmaceuticals, Inc. 32
AnaptysBio, Inc. 33
Angion Biomedica Corp. 34
Aquinox Pharmaceuticals Inc. 35
Auspex Pharmaceuticals, Inc. 36
Biogen Idec Inc. 37
BiOrion Technologies B.V. 38
Boehringer Ingelheim GmbH 39
Bristol-Myers Squibb Company 40
Carolus Therapeutics, Inc. 41
Celgene Corporation 42
Chong Kun Dang Pharmaceutical Corp. 43
Compugen Ltd. 44
Corridor Pharmaceuticals Inc. 45
Digna Biotech, S.L. 46
Eli Lilly and Company 47
F. Hoffmann-La Roche Ltd. 48
FibroGen, Inc. 49
Five Prime Therapeutics, Inc. 50
Galectin Therapeutics, Inc. 51
GenKyoTex S.A. 52
Gilead Sciences, Inc. 53
GlaxoSmithKline plc 54
HanAll Biopharma Co., Ltd. 55
Histocell S.L. 56
iBio, Inc. 57
IMMD Inc. 58
ImmuneWorks, LLC 59
IntelGenx Corp. 60
InterMune, Inc. 61
Inventiva SAS 62
Kasiak Research Pvt. Ltd. 63
Kyorin Pharmaceutical Co., Ltd. 64
Lanthio Pharma B.V. 65
Lpath, Inc. 66
LTT Bio-Pharma Co., Ltd. 67
MedImmune, LLC 68
Mesoblast Limited 69
miRagen Therapeutics, Inc. 70
Moerae Matrix, Inc. 71
MSM Protein Technologies, Inc. 72
NicOx S.A. 73
Pacific Therapeutics Ltd. 74
Pharmaxis Limited 75
Pluristem Therapeutics Inc. 76
Progenra, Inc. 77
Promedior, Inc. 78
ProMetic Life Sciences Inc. 79
Pulmatrix, Inc. 80
RestorGenex Corporation 81
Rhizen Pharmaceuticals SA 82
Sanofi 83
Therametrics holding AG 84
Vectura Group plc 85
Pulmonary Fibrosis – Therapeutics Assessment 86
Assessment by Monotherapy Products 86
Assessment by Combination Products 87
Assessment by Target 88
Assessment by Mechanism of Action 92
Assessment by Route of Administration 95
Assessment by Molecule Type 97
Drug Profiles 99
(pentoxifylline + acetylcysteine) – Drug Profile 99
ABC-294640 – Drug Profile 100
AEOL-10150 – Drug Profile 102
AM-0010 – Drug Profile 105
ANG-3070 – Drug Profile 106
ANG-3298 – Drug Profile 107
Antibodies to Inhibit LPA1 for Idiopathic Pulmonary Fibrosis – Drug Profile 108
AQX-1125 – Drug Profile 109
BB-3 – Drug Profile 111
BMS-986020 – Drug Profile 113
BOT-191 – Drug Profile 114
C-301 – Drug Profile 115
CC-539 – Drug Profile 116
CC-90001 – Drug Profile 117
CG-1011 – Drug Profile 118
CGEN-25009 – Drug Profile 119
CKD-942 – Drug Profile 120
CT-140 – Drug Profile 121
CT-2009 – Drug Profile 122
DB-02901 – Drug Profile 123
disitertide – Drug Profile 124
Drug for Idiopathic Pulmonary Fibrosis – Drug Profile 126
Drugs to Antagonize IGF-1 Receptor for Acute Lung Injury and Pulmonary Fibrosis – Drug Profile 127
FG-3019 – Drug Profile 128
FPA-008 – Drug Profile 130
GKT-137831 – Drug Profile 131
GR-MD-02 – Drug Profile 132
HC-016 – Drug Profile 134
HL-156FIB – Drug Profile 135
HR-017 – Drug Profile 136
IBIOCFB-03 – Drug Profile 137
ICG-001 – Drug Profile 138
IMD-1041 – Drug Profile 139
INT-0024 – Drug Profile 140
interferon gamma-1b – Drug Profile 141
ITMN-10534 – Drug Profile 142
ITMN-14440 – Drug Profile 143
ITMN-30162 – Drug Profile 144
IVA-337 – Drug Profile 145
IW-001 – Drug Profile 146
KBP-7018 – Drug Profile 147
lebrikizumab – Drug Profile 148
LP2 – Drug Profile 150
Lpathomab – Drug Profile 151
LT-0011 – Drug Profile 152
LY-2109761 – Drug Profile 153
MGN-4220 – Drug Profile 154
MMI-0100 – Drug Profile 155
Monoclonal Antibody for Idiopathic Pulmonary Fibrosis – Drug Profile 156
MSM-735 – Drug Profile 157
MSX-122 – Drug Profile 158
NAS-911 – Drug Profile 160
NCX-466 – Drug Profile 161
nintedanib – Drug Profile 162
Oligonucleotides for Respiratory and Oncology – Drug Profile 166
omipalisib – Drug Profile 167
P-007 – Drug Profile 168
P-17 – Drug Profile 169
P-529 – Drug Profile 171
PBF-1250 – Drug Profile 173
PBI-4050 – Drug Profile 174
phytate sodium – Drug Profile 175
pirfenidone – Drug Profile 176
PRI-724 – Drug Profile 177
PRM-151 – Drug Profile 179
PUR-1500 – Drug Profile 181
PXS-25 – Drug Profile 182
PXS-4820 – Drug Profile 183
PXS-5033-A – Drug Profile 184
PXS-64 – Drug Profile 185
Recombinant Human Follistatin – Drug Profile 186
Refacell-IPF – Drug Profile 187
RNAi Oligonucleotides for Idiopathic Pulmonary Fibrosis – Drug Profile 188
RP-6503 – Drug Profile 189
SAR-156597 – Drug Profile 190
SD-560 – Drug Profile 191
simtuzumab – Drug Profile 192
Small Molecule 1 for Chronic Respiratory Diseases – Drug Profile 194
Small Molecule 2 for Chronic Respiratory Diseases – Drug Profile 195
Small Molecule to Antagonize Integrin Alpha V for Idiopathic Pulmonary Fibrosis – Drug Profile 196
Small Molecule to Inhibit NOX 1 and 4 – Drug Profile 197
Small Molecules to Antagonize LPA1 Receptor for Pulmonary Fibrosis – Drug Profile 198
Small Molecules to Inhibit LOXL2 for Oncology and Fibrosis – Drug Profile 199
Small Molecules to Inhibit USP34 for Idiopathic Pulmonary Fibrosis – Drug Profile 200
SPL-334 – Drug Profile 201
Stem Cell Therapy for Asthma and Pulmonary Fibrosis – Drug Profile 202
Stem Cell Therapy for Idiopathic Lung Fibrosis – Drug Profile 203
Stem Cell Therapy for Pulmonary Fibrosis – Drug Profile 204
STX-100 – Drug Profile 205
Synthetic Peptides to Antagonize TGF-Beta Receptor for Diabetic Foot Ulcers, Pulmonary Fibrosis and Dermatology – Drug Profile 206
Synthetic Peptides to Inhibit PDE-4A4 for Pulmonary Fibrosis and Nerve Injury – Drug Profile 208
TD-139 – Drug Profile 209
tipelukast – Drug Profile 210
tralokinumab – Drug Profile 212
vismodegib – Drug Profile 214
Pulmonary Fibrosis – Recent Pipeline Updates 217
Pulmonary Fibrosis – Dormant Projects 265
Pulmonary Fibrosis – Discontinued Products 269
Pulmonary Fibrosis – Product Development Milestones 270
Featured News & Press Releases 270
Appendix 280
Methodology 280
Coverage 280
Secondary Research 280
Primary Research 280
Expert Panel Validation 280
Contact Us 281
Disclaimer 281
【レポート販売概要】
■ タイトル：肺線維症(Pulmonary Fibrosis)の治療薬パイプライン動向（2015年上半期版）■ 英文：Pulmonary Fibrosis - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6017IDB
■ 調査対象地域：グローバル
- L-Quebrachitolの世界市場L-Quebrachitol (CAS 642-38-6) Market Research Report 2013 presents comprehensive data on l-quebrachitol markets globally and regionally (Europe, Asia, North America etc.) The L-Quebrachitol (CAS 642-38-6) Market Research Report 2013 includes l-quebrachitol description, covers its application areas and related patterns. It overviews l-quebrachitol market, names l-quebrachitol producers and indicate …
- Effient（ACS/急性冠症候群）：医薬品市場予測及び分析（～2023）Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which are …
- 電子棚ラベルの世界市場：製品タイプ別（LCD、セグメント化された電子ペーパー、およびフルグラフィック電子ペーパー）、コンポーネント別（ディスプレイ、バッテリー、トランシーバー、マイクロプロセッサー、その他）、通信技術別（無線周波数、赤外線、近距離無線通信、その他） 、店舗タイプ別（ハイパーマーケット、スーパーマーケット、非食品小売店、専門店、その他）The electronic shelf label market size was valued at $624.70 million in 2018, and is projected to reach $2.16 billion by 2026, growing at a CAGR of 16.70% from 2019 to 2026. The electronic shelf label (ESL) system is used for displaying product pricing on shelves. It utilizes wireless communication networks such as radio frequency (RF) technology and infrared (IR) technology to communicate with th …
- 特殊食品成分の世界市場：機能性食品成分、甘味料、香料、特殊澱粉、酸味料、保存料、乳化剤、着色料、酵素、スターターカルチャーThe specialty food ingredients market is projected to reach the value of USD 91.2 Billion by 2020, at a CAGR of 5.5% from 2015. The market is driven by the increasing R&D and technological innovations, growing need for convenient foods which quickly suffice the need for the moment, nutritional and tasty foods, and vast emergence of end product applications. The functional foods have increased in d …
- フラックツリーの世界市場2019-2023About Frac Tree A frac tree, also referred to as frac stack, is specifically, used in a hydraulically fractured well. It includes a set of high- pressure valves, fittings, spools connected to the top of a well to direct and control the flow of fluids. Technavio’s analysts forecast the global frac tree market to grow at a CAGR of 5.24% during the period 2019-2023. Covered in this report The report …
- 洋上風力発電の世界市場2015-2019About Offshore Wind Power Offshore wind power is the generation of electricity from wind by constructing wind farms in water bodies. It is estimated to be one of the cheapest and cleanest forms of electricity generation. Offshore wind turbines are larger in size and have greater wind speed compared with onshore wind turbines. Offshore wind power offers various advantages compared with onshore wind …
- 世界におけるX線画像診断（医療機器）市場MediPoint: Diagnostic X-ray Imaging - Global Analysis and Market Forecasts Summary An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic X-ray imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagn …
- 動力式外科器具の世界市場：電気式、電池式、空圧式The global powered surgical instruments market is estimated to be worth around USD 1.7 Billion in 2014 and is expected to reach around USD 2.2 Billion to grow at a CAGR of 4.1% during the forecast period of 2015 to 2020. This market is mainly driven by increasing aging population, high prevalence of chronic disorders requiring surgical interventions, and high disposable income among consumers. Mor …
- 世界のシステム管理ソフト市場動向（2012-2016）TechNavio’s analysts forecast the Global Systems Management Software market to grow at a CAGR of 6.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to enhance employee productivity and reduce costs. The Global Systems Management Software market has also been witnessing the emergence of cloud-based systems management solutions. However, man …
- クリーンラベル成分の世界市場：種類別（自然色、天然香料、デンプン＆甘味料、天然防腐剤、その他）、用途別（飲料、ベーカリー＆菓子、ソース＆調味料、乳製品＆冷凍デザート、その他の加工食品）、フォーム別（粉末、液体）The clean label ingredients market was valued at $38.8 billion in 2018, and is projected to reach $64.1 billion by 2026, growing at a CAGR of 6.8% from 2019 to 2026. Clean label products are those which are made by using very few ingredients and are natural or organic. Although organic farming is old term, clean label ingredients is a new trend in the food & beverage industry. Clean label does not …
- グローバルにおける統合失調症（Schizophrenia）治療薬市場及びパイプライン分析Schizophrenia is defined as a disorder of the brain which impacts the way in which a person acts, thinks, and sees the world. It has been observed that the patients suffering from schizophrenia generally tend to have an altered perception of reality, which reveals a significant diversion from the reality. In most cases, schizophrenia is diagnosed among people in the late teens or early adulthood. …
- 糖尿病網膜症（Diabetic Retinopathy）：グローバル臨床試験レビュー（2014年上半期）Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Retinopathy. It includes an overview of the trial numbers and their r …
- 埋込用樹脂の世界市場：エポキシ樹脂、ポリウレタン樹脂、シリコーン樹脂、ポリエステル、ポリアミドThe global potting compound market size, in terms of value, is projected to reach USD 3.13 Billion by 2021, at a CAGR of 3.7% between 2016 and 2021. The high demand from the electronics industry, increasing miniaturization of electronic devices and continuous new product launches and expansion activities undertaken by different companies are the key factors for the growth of the global potting com …
- 世界のラゲッジ（手荷物）市場動向（2012-2016）TechNavio’s analysts forecast the Global Luggage market to grow at a CAGR of 8.1 percent CAGR over the period 2012-2016. One of the key factors contributing to this market growth is the increasing disposable income of the consumers. The Global Luggage market has also been witnessing a trend of an increased per capita expenditure on luggage by the consumers. However, the increasing competition from …
- プレバイオティクス成分の世界市場予測：オリゴ糖、イヌリン、ポリデキストロースThe prebiotic ingredients market is projected to grow at a CAGR of 11.6%, in terms of value, from 2017 to reach a projected value of USD 6.91 Billion by 2022. The market is driven by the demand from Asia-Pacific and Europe. Multi-functional nature of prebiotic ingredients, ease of incorporation in a wide range of applications, and increase in health consciousness among the consumers are the factor …
